Follow the pharma money

3:31 PM ET Thu, 25 Aug 2016

To blame the healthcare system is what Mylan CEO Heather Bresch told CNBC today in explaining why the price of her company's EpiPen has seen price hikes of 400%. CNBC's Meg Tirrell breaks down the pharma supply chain system.